Complex alterations in microglial M1/M2 markers during the development of epilepsy in two mouse models

Epilepsia

Volumn 56, Issue 6, 2015, Pages 895-905

  Benson, Melissa J ^a   Manzanero, Silvia ^a   Borges, Karin ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cytokine; Inflammation; Kainate; Pilocarpine; Seizure; Status epilepticus

Indexed keywords

ARGINASE 1; CD11B ANTIGEN; CD16 ANTIGEN; CD86 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; KAINIC ACID; M1 PROTEIN; MESSENGER RNA; PILOCARPINE; PROTEIN; PROTEIN M2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ARG1 PROTEIN, MOUSE; ARGINASE; BETA N ACETYLHEXOSAMINIDASE; CHI3L3 PROTEIN, MOUSE; CONVULSANT AGENT; CYTOKINE; LECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL INFILTRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; FLOW CYTOMETRY; HIPPOCAMPUS; INFLAMMATION; MALE; MICROGLIA; MOUSE; MOUSE MODEL; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEIZURE; UPREGULATION; ANALYSIS OF VARIANCE; ANIMAL; CHEMICALLY INDUCED; CLASSIFICATION; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TIME;

ANALYSIS OF VARIANCE; ANIMALS; ARGINASE; BETA-N-ACETYLHEXOSAMINIDASES; CONVULSANTS; CYTOKINES; DISEASE MODELS, ANIMAL; EPILEPSY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; KAINIC ACID; LECTINS; MALE; MICE; MICROGLIA; PILOCARPINE; TIME FACTORS;

EID: 84930478595     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12960     Document Type: Article

References (45)

1. Perry VH, Nicoll JA, Holmes C,. Microglia in neurodegenerative disease. Nat Rev Neurol 2010; 6: 193-201.
2. Boche D, Perry V, Nicoll J,. Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol 2013; 39: 3-18.
3. Colton CA,. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 2009; 4: 399-418.
4. Gordon S, Martinez FO,. Alternative activation of macrophages: mechanism and functions. Immunity 2010; 32: 593-604.
5. Mosser DM, Edwards JP,. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969.
6. Hu X, Li P, Guo Y, et al., Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 2012; 43: 3063-3070.
7. Kigerl KA, Gensel JC, Ankeny DP, et al., Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009; 29: 13435-13444.
8. Taniwaki Y, Kato M, Araki T, et al., Microglial activation by epileptic activities through the propagation pathway of kainic acid-induced hippocampal seizures in the rat. Neurosci Lett 1996; 217: 29-32.
9. Avignone E, Ulmann L, Levavasseur F, et al., Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling. J Neurosci 2008; 28: 9133-9144.
10. Shapiro LA, Wang L, Ribak CE,. Rapid astrocyte and microglial activation following pilocarpine-induced seizures in rats. Epilepsia 2008; 49: 33-41.
11. Borges K, Gearing M, McDermott DL, et al., Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model. Exp Neurol 2003; 182: 21-34.
12. Toyoda I, Bower MR, Leyva F, et al., Early activation of ventral hippocampus and subiculum during spontaneous seizures in a rat model of temporal lobe epilepsy. J Neurosci 2013; 33: 11100-11115.
13. Beach T, Woodhurst W, MacDonald D, et al., Reactive microglia in hippocampal sclerosis associated with human temporal lobe epilepsy. Neurosci Lett 1995; 191: 27-30.
14. Crespel A, Coubes P, Rousset M-C, et al., Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis. Brain Res 2002; 952: 159-169.
15. Boer K, Spliet W, Van Rijen P, et al., Evidence of activated microglia in focal cortical dysplasia. J Neuroimmunol 2006; 173: 188-195.
16. Najjar S, Pearlman D, Miller DC, et al., Refractory epilepsy associated with microglial activation. Neurologist 2011; 17: 249-254.
17. Vezzani A, Conti M, De Luigi A, et al., Interleukin-1β immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 1999; 19: 5054-5065.
18. Riazi K, Galic MA, Kuzmiski JB, et al., Microglial activation and TNFα production mediate altered CNS excitability following peripheral inflammation. Proc Natl Acad Sci U S A 2008; 105: 17151-17156.
19. Samland H, Huitron-Resendiz S, Masliah E, et al., Profound increase in sensitivity to glutamatergic-but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6. J Neurosci Res 2003; 73: 176-187.
20. Vezzani A, Moneta D, Richichi C, et al., Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia 2002; 43: 30-35.
21. Vezzani A, Moneta D, Conti M, et al., Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci U S A 2000; 97: 11534-11539.
22. Maroso M, Balosso S, Ravizza T, et al., Interleukin-1β biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics 2011; 8: 304-315.
23. Marchi N, Granata T, Freri E, et al., Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics. PLoS ONE 2011; 6: e18200.
24. Ben-Ari Y,. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 1985; 14: 375-403.
25. Mazzuferi M, Kumar G, Rospo C, et al., Rapid epileptogenesis in the mouse pilocarpine model: video-EEG, pharmacokinetic and histopathological characterization. Exp Neurol 2012; 238: 156-167.
26. Bouilleret V, Ridoux V, Depaulis A, et al., Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: electroencephalography, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy. Neuroscience 1999; 89: 717-729.
27. Wilcox KS, Dixon-Salazar T, Sills GJ, et al., Issues related to development of new antiseizure treatments. Epilepsia 2013; 54: 24-34.
28. Marchi N, Oby E, Batra A, et al., In vivo and in vitro effects of pilocarpine: relevance to ictogenesis. Epilepsia 2007; 48: 1934-1946.
29. Smeland OB, Hadera MG, McDonald TS, et al., Brain mitochondrial metabolic dysfunction and glutamate level reduction in the pilocarpine model of temporal lobe epilepsy in mice. J Cereb Blood Flow Metab 2013; 33: 1090-1097.
30. Gelderblom M, Leypoldt F, Steinbach K, et al., Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009; 40: 1849-1857.
31. Low PC, Manzanero S, Mohannak N, et al., PI3Kδ inhibition reduces TNF secretion and neuroinflammation in a mouse cerebral stroke model. Nat Commun 2014; 5: 3450. doi: 10.1038/ncomms4450.
32. Marchi N, Johnson AJ, Puvenna V, et al., Modulation of peripheral cytotoxic cells and ictogenesis in a model of seizures. Epilepsia 2011; 52: 1627-1634.
33. Costa-Ferro ZS, Souza BS, Leal MM, et al., Transplantation of bone marrow mononuclear cells decreases seizure incidence, mitigates neuronal loss and modulates pro-inflammatory cytokine production in epileptic rats. Neurobiol Dis 2012; 46: 302-313.
34. Lieberman AP, Pitha PM, Shin HS, et al., Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci U S A 1989; 86: 6348-6352.
35. Cahoy JD, Emery B, Kaushal A, et al., A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 2008; 28: 264-278.
36. Quirie A, Demougeot C, Bertrand N, et al., Effect of stroke on arginase expression and localization in the rat brain. Eur J Neurosci 2013; 37: 1193-1202.
37. Marchi N, Fan Q, Ghosh C, et al., Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol Dis 2009; 33: 171-181.
38. Ravizza T, Balosso S, Vezzani A,. Inflammation and prevention of epileptogenesis. Neurosci Lett 2011; 497: 223-230.
39. Somera-Molina KC, Nair S, Van Eldik LJ, et al., Enhanced microglial activation and proinflammatory cytokine upregulation are linked to increased susceptibility to seizures and neurologic injury in a 'two-hit' seizure model. Brain Res 2009; 1282: 162-172.
40. Serrano G, Lelutiu N, Rojas A, et al., Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus. J Neurosci 2011; 31: 14850-14860.
41. Rakhade SN, Jensen FE,. Epileptogenesis in the immature brain: emerging mechanisms. Nat Rev Neurol 2009; 5: 380-391.
42. Pernot F, Heinrich C, Barbier L, et al., Inflammatory changes during epileptogenesis and spontaneous seizures in a mouse model of mesiotemporal lobe epilepsy. Epilepsia 2011; 52: 2315-2325.
43. Kumar A, Stoica BA, Sabirzhanov B, et al., Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states. Neurobiol Aging 2013; 34: 1397-1411.
44. Balosso S, Ravizza T, Aronica E, et al., The dual role of TNF-α and its receptors in seizures. Exp Neurol 2013; 247: 267-271.
45. Banati RB, Newcombe J, Gunn RN, et al., The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 2000; 123: 2321-2337.